Breast Cancer Arabia
    • 15 May

    Needle Biopsies May Be Underused for Breast Cancer Patients

    • May 15, 2014
    • Breast Cancer Arabia Team
    • 0

    NEW YORK (Reuters Health) – While most women should undergo a needle biopsy for breast cancer diagnosis, some surgeons opt for open biopsies instead, a new study found.   The difference may be a matter of surgeon experience, researchers say, […]

    read more
    • 12 May

    Public Ignorant About Radiation Dose of Mammography

    • May 12, 2014
    • Breast Cancer Arabia Team
    • 0

    SAN DIEGO — Many people overestimate their exposure to ionizing radiation from mammography, a new study shows.   Asked to compare the radiation dose from a mammogram to five other benchmarks, a sample of 1350 people (including 2 men) ranked […]

    read more
  • Chemo for Breast Cancer Tied to Long Unemployment
    • 21 Apr

    Chemo for Breast Cancer Tied to Long Unemployment

    • Apr 21, 2014
    • Breast Cancer Arabia Team
    • 0

    Almost one third of early-stage breast cancer survivors who were working when they began treatment were unemployed 4 years later, according to a new longitudinal American study.   And chemotherapy was significantly associated with a heightened risk for that long-term […]

    read more
  • Lung Cancer: A Dose-Dependent Risk After Breast Cancer RT
    • 14 Apr

    Lung Cancer: A Dose-Dependent Risk After Breast Cancer RT

    • Apr 14, 2014
    • Breast Cancer Arabia Team
    • 0

    VIENNA — The risk of developing a primary lung cancer after radiotherapy for breast cancer increases in a dose-response manner, with these odds jumping 17-fold in smokers, according to new research from a cohort of more than 23,000 irradiated patients […]

    read more
  • Fertility Drugs Not Tied to Long Term Breast Cancer Risk
    • 07 Apr

    Fertility Drugs Not Tied to Long Term Breast Cancer Risk

    • Apr 07, 2014
    • Breast Cancer Arabia Team
    • 0

    NEW YORK (Reuters Health) – Despite some evidence that fertility treatments increase the risk of breast cancer, a large, long term study has found no added risk.   Nearly 10,000 women who received drugs to stimulate ovulation were no more […]

    read more
  • Buparlisib Shows Promise in Metastatic Breast Cancer
    • 03 Apr

    Buparlisib Shows Promise in Metastatic Breast Cancer

    • Apr 03, 2014
    • Breast Cancer Arabia Team
    • 0

    NEW YORK (Reuters Health) – Buparlisib combined with letrozole shows promise in treating estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer, according to the early-phase Stand Up to Cancer study.   “The combination of letrozole and buparlisib was overall safe and […]

    read more
  • In Most EU Countries, Breast Cancer Mortality Has Declined
    • 28 Mar

    In Most EU Countries, Breast Cancer Mortality Has Declined

    • Mar 28, 2014
    • Breast Cancer Arabia Team
    • 0

    Breast cancer mortality has declined across Europe, but there are still notable differences between countries, according to new data presented at the 9th European Breast Cancer Conference in Glasgow, United Kingdom.   Researchers reported that the death rate from breast […]

    read more
  • Could Half of All Breast Cancers Be Prevented?
    • 22 Mar

    Could Half of All Breast Cancers Be Prevented?

    • Mar 22, 2014
    • Breast Cancer Arabia Team
    • 0

    NEW YORK (Reuters Health) – If girls and women of all ages adopted healthier lifestyle behaviors and the highest-risk women took preventive drugs like tamoxifen, the authors of a new report say fully half of breast cancers in the U.S. […]

    read more
  • Reducing the recurrence of aggressive breast cancer
    • 21 Nov

    Reducing the recurrence of aggressive breast cancer

    • Nov 21, 2013
    • Breast Cancer Arabia Team
    • 0

    In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center are exploring a new method to potentially prevent recurrence of an early stage, aggressive type of breast cancer. The pilot study, conducted by Joe Baar, MD, Director […]

    read more
    • 11 Oct

    ‘Two peptide agent combination might block tumour growth’

    • Oct 11, 2013
    • Breast Cancer Arabia Team
    • 0

    This early test of the two agents in a breast cancer model suggests that the double hit can stifle tumour progression, avoid drug resistance and cause few side effects, say researchers at the Ohio State University Comprehensive Cancer Center – […]

    read more
    • Page 13 of 16
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
  • REGIONAL SUPPORT
    • flag-egypt-1
    • bcfoe-logo
    • flag-lebanon-1
    • faire-face-logo-1
  • USEFUL LINKS
    - Breast cancer article library


    - Breast Self Examination


    - Breast cancer stories


    - Male breast cancer


    - Get involved

  • CONNECT

    social 1social 2social 3social - linkdin


    CONTACT US


  • IMPORTANT NOTICE

    Breast Cancer Arabia®, BCA® and Dubai Goes Pink® - do not use our name, or any of our marks or logos without first getting our written permission.

COPYRIGHT Breast Cancer Arabia Foundation 2014

Scroll